Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Serum amyloid A augments mucosal immunity by opposing resolving lipoxinA4 signaling in chronic lung disease

Steven Bozinovski, Mohib Uddin, Ross Vlahos, Michelle Thompson, Anne-Sophie Merritt, Peter Wark, Anastasia Hutchinson, Louis Irving, Bruce Levy, Gary Anderson
European Respiratory Journal 2011 38: 4907; DOI:
Steven Bozinovski
1Pharmacology, University of Melbourne, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohib Uddin
3Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ross Vlahos
1Pharmacology, University of Melbourne, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Thompson
2Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Sophie Merritt
1Pharmacology, University of Melbourne, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Wark
4Respiratory and Sleep Medicine, University of Newcastle, Newcastle, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasia Hutchinson
2Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis Irving
2Respiratory Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Levy
3Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Anderson
1Pharmacology, University of Melbourne, Parkville, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Persistent innate immune activation contributes to tissue destruction in chronic obstructive pulmonary disease (COPD). Altered responses to glucocorticosteroids (GC) may further compromise host defense in chronic lung diseases. We previously identified SAA as a GC resistant systemic COPD biomarker and here, characterized its function in orchestrating mucosal inflammatory responses that contribute to neutrophil accumulation.

Methods: Three separate patient cohorts were investigated involving 81 patients.

Results: In a prospective study of competing ALX/FPR2 ligands during COPD exacerbation, circulating SAA levels were markedly and disproportionately increased relative to LXA4. Secreted SAA levels in COPD BAL fluid correlated with interleukin-8 and the neutrophil activation marker, neutrophil elastase. SAA was also detected in COPD lung in close proximity to airway epithelia, and in vitro SAA triggered pro-inflammatory mediator (MCP-1, GM-CSF and IL-8) release by airway epithelial cells in an ALX/FPR2 receptor-dependent manner. Lipoxin A4 (LXA4) blocked SAA initiated epithelial responses via allosteric inhibition at ALX/FPR2 (pA2 13 nM). When administered directly into murine lung, SAA initiated robust acute inflammation that was significantly inhibited by equivalent amounts of 15-epi-LXA4 but not dexamethasone. Tissue macrophages (CD68+) colocalised with lung SAA and the GC dexamethasone markedly increased SAA production by THP-1 macrophages (pEC50 43 nM).

Conclusions: Together, these findings implicate airway SAA production as a mediator of GC resistant lung inflammation that can overwhelm organ protective signaling by lipoxins at ALX/FPR2 receptors.

  • © 2011 ERS
Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Serum amyloid A augments mucosal immunity by opposing resolving lipoxinA4 signaling in chronic lung disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Serum amyloid A augments mucosal immunity by opposing resolving lipoxinA4 signaling in chronic lung disease
Steven Bozinovski, Mohib Uddin, Ross Vlahos, Michelle Thompson, Anne-Sophie Merritt, Peter Wark, Anastasia Hutchinson, Louis Irving, Bruce Levy, Gary Anderson
European Respiratory Journal Sep 2011, 38 (Suppl 55) 4907;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Serum amyloid A augments mucosal immunity by opposing resolving lipoxinA4 signaling in chronic lung disease
Steven Bozinovski, Mohib Uddin, Ross Vlahos, Michelle Thompson, Anne-Sophie Merritt, Peter Wark, Anastasia Hutchinson, Louis Irving, Bruce Levy, Gary Anderson
European Respiratory Journal Sep 2011, 38 (Suppl 55) 4907;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Insufficient autophagy is involved in accelerated cellular senescence in the pathophysiology of COPD
  • Up-regulation of decoy receptor D6 in COPD
Show more 508. Novel mechanisms in COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society